Aquilo Capital Management, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 279 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
Aquilo Capital Management, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2024$12,351,588
-28.5%
114,600
-37.1%
11.91%
-8.1%
Q1 2024$17,278,844
-26.5%
182,151
-28.5%
12.95%
-11.6%
Q4 2023$23,505,242
+23.5%
254,827
-32.8%
14.65%
-15.1%
Q3 2023$19,037,900
-32.9%
379,090
-15.6%
17.25%
+9.7%
Q2 2023$28,375,978
+1.3%
448,987
-27.9%
15.72%
+35.4%
Q1 2023$28,021,077
+9.9%
622,829
+7.1%
11.61%
+21.3%
Q4 2022$25,487,256
-26.2%
581,768
+11.0%
9.57%
-23.1%
Q3 2022$34,544,000
-4.6%
524,268
-26.8%
12.45%
+0.8%
Q2 2022$36,192,000
-27.5%
716,539
-8.3%
12.35%
+68.3%
Q1 2022$49,925,000
-27.8%
781,539
+21.1%
7.34%
-6.4%
Q4 2021$69,144,000
+28.9%
645,539
+23.7%
7.84%
-19.5%
Q3 2021$53,633,000
+35.9%
521,673
+16.3%
9.74%
-5.0%
Q2 2021$39,451,000
-4.1%
448,512
+6.0%
10.25%
+37.9%
Q1 2021$41,129,000
-3.5%
423,012
+11.3%
7.43%
-16.1%
Q4 2020$42,618,000
+19.2%
380,012
-1.5%
8.86%
+134.0%
Q3 2020$35,757,000
+45.5%
385,727
+22.4%
3.78%
-23.6%
Q2 2020$24,572,000
+902.5%
315,029
+928.9%
4.96%
+356.7%
Q1 2019$2,451,00030,6181.08%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 559,381$41,098,00015.69%
Casdin Capital, LLC 940,000$69,061,800,0007.15%
Ghost Tree Capital, LLC 325,000$23,878,0006.08%
CADIAN CAPITAL MANAGEMENT, LP 1,418,704$104,232,0004.96%
DAFNA Capital Management LLC 123,218$9,053,0003.40%
BVF INC/IL 437,565$32,148,0003.38%
Opaleye Management Inc. 105,000$7,714,0002.79%
Cormorant Asset Management, LP 493,000$36,221,0002.20%
Novo Holdings A/S 170,667$12,539,0002.15%
Artal Group S.A. 600,000$44,082,0001.77%
View complete list of BLUEPRINT MEDICINES CORP shareholders